Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality

Mark Jones*, Chris Del Mar, Rokuro Hama

*Corresponding author for this work

Research output: Contribution to journalLetterResearchpeer-review

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)9-10
Number of pages2
JournalThe Lancet Respiratory Medicine
Issue number7
Publication statusPublished - 2014

Cite this